GlaxoSmithKline (GSK) is a global pharmaceutical company headquartered in London. It has a portfolio of products for major disease areas such as asthma, cancer, infections and mental health. GSK was formed in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. It has operations in over 120 countries and sells products in over 150 countries. Its top competitors include Johnson & Johnson, Pfizer, Merck and AstraZeneca.

1. Glaxo Smith Kline

2. GSK’S IntroductionGlaxoSmithKline often abbreviated to GSK, is a global pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom.

3. GSK’S IntroductionIt is world’s third largest pharmaceutical company measured by revenues ( after Johnson and Johnson and Pfizer.It has a portfolio of products for major disease areas including asthma, cancer, virus control, infections, mental health, diabetes and digestive conditions.

4. History GlaxoSmithKline plc is a public limited company incorporated on 6th December 1999 under English law. Its shares are listed on the London Stock Exchange and the New York Stock Exchange.

5. On 27th December 2000 the company acquired Glaxo Wellcome plc and SmithKline Beecham plc, both English public limited companies, by way of a scheme of arrangement for the merger of the two companies.History GSK and its subsidiary and associated undertakings constitute a major global healthcare group engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products.GSK has its corporate head office in London and has its US headquarters in Research Triangle Park, North Carolina, with operations in some 120 countries, and products sold in over 150 countries.

6. Chairman: Sir Christopher GentChief Executive Officer: Andrew Witty

7. GSK’s MissionGSK MISSIONGROWMISSIONSIMPLYFYDELIVER

8. GSK’S Mission Grow a diversified global business – We are diversifying our business to create a more balanced product portfolio and move away from a reliance on traditional ‘white pill/western markets’. We are investing in key growth areas such as Emerging Markets, Japan, Vaccines and our Consumer Healthcare business..

9. GSK’S MissionDeliver more products of value – We aim to sustain an industry-leading pipeline of products, ensuring that they demonstrate value for healthcare providers. Our R&D strategy is built around focusing on the best science, diversifying through externalisation of research, and improving the returns on investment.

10. GSK’S MissionSimplify the operating model – GSK is a large and complex organisation. We are transforming our operating model to reduce complexities, improve efficiency and reduce costsProducts Prescription medicinesVaccinesConsumer Healthcare

11. PRESCRIPTION MEDICINES

12. ALLI-WEIGHT LOSS DRUG

13. AVANDIA-DIABETIS CONTROL

14. ROTAVIRUS VACCINE ROTARIX

15. VACCINE FOR MEASLES

16. CONSUMER HEALTHCARE PRODUCTS

17. CONSUMER HEALTHCARE PRODUCTS

18. Two other companiesStiefel, a GSK company— A Global Leader in DermatologyViiV Healthcare — a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people

19. STIEFEL-A GSK COMPANY

20. VIIV- HEALTHCARE COMPANY

21. Turnover ( in billion pounds)2009 28.42008 24.42007 22.72006 23.22005 21.7

22. World market by geographic region value(billion pounds) % of totalUSA 187 40Europe 131 28France 25 5Germany 24 5Italy 16 3UK 12 3Rest of World 150 32Emerging markets 66 14Asia Pacific 20 4Japan 50 11Canada 11 2

23. Regional analysis (2009) (2008) cer% pnd%USA 9,180 8,894 (13) 3Europe 7,681 6,483 9 18Emerging Markets 2,973 2,290 20 30Asia Pacific/Japan 2,700 1,918 16 41Other trading‡ 1,180 796 31 48 23,714 20,381 2 16

24. CER% represents growth at constant exchange rates.Pound % growth at actual exchange rates.

25. Consumer Healthcare turnover(million pounds) (2009) (2008) cer% pound %Over the counter 2,319 1935 8 20MedicinesOral healthcare 1484 1240 7 20Nutritional healthcare 851 796 3 7

26. Sales Trend

27. Five countries chosenUSA

28. JAPAN

29. GERMANY

30. SWITZERLAND

31. UKCOMPETITORS IN USA NAME OF THE COMPANYJohnson & JohnsonAbbott LaboratoriesMerck & Co. Eli lillyBristol-Myers SquibbTOTAL REVENUE(IN USD BILLIONS )61.9030.76 27.4321.8418.81

32. JOHNSON &JOHNSON

33. ABBOT LABORATARIES

34. MERCK &CO.

35. ELI LILLY

36. BRISTOL-MYERS SQUIBB

37. COMPETITORS IN JAPANNAME OF THE COUNTRYTAKEDAPHARMACEUTICAL.ASTELLAS PHARMADAIICHI SANKYO 9EISAICHUGAI PHARMACEUTICAL . TOTAL REVENUE (IN USD BILLIONS)15.610.795.52.0

38. TAKEDA PHARMACEUTICALS

39. ASTELLAS PHARMA

40. DAIICHI SANKYO

41. EISAI

42. CHUGAI PHARMACEUTICALS

43. COMPETITORS IN GERMANYNAME OF THE COUNTRYBAYERBOEHRINGER INGELHEIMMERCK kGaA TOTAL REVENUE (IN USD BILLIONS)22.316.95.17

44. BAYER

45. BOEHRINGER INGELHEIM

46. MERCK KGAA

47. COMPETITORS IN SWITZERLANDNAME OF THE COUNTRYHOFFMAN LA ROCHENOVARTISNYCOMED TOTAL REVENUE (IN USD BILLIONS)47.3544.274.26

48. HOFFMAN LA ROCHE

49. NOVARTIS

50. NYCOMED

51. COMPETITORS IN UKNAMEOF THE COMPANYTOTAL REVENUE (IN USD BILLIONS)45.8332.81GlaxoSmithKlineAstraZeneca